Can Bladder Cancer be Prevented?

No, bladder cancer cannot be entirely prevented. It is a fact of life that some people are simply unfortunate enough to develop bladder cancer. Adopting a lifestyle that avoids tobacco smoking, maintains a balanced diet, limits exposure to harmful chemicals, ensures adequate hydration, and involves being mindful of certain medications and supplements can contribute to a healthier life. However, these measures do not necessarily prevent bladder cancer.

Comments

What Is Kidney Cancer?

Kidney cancer is a type of cancer that starts in the kidneys, the two bean-shaped organs located on either side of the spine, just below the rib cage. The kidneys play a crucial role in filtering blood, removing waste products and excess fluids, and producing urine. Understanding kidney cancer is vital for early detection and effective treatment. This comprehensive overview covers the basics of kidney cancer, including its types, causes, symptoms, and treatment options. What is Kidney Cancer? Kidney cancer occurs when cells in the kidney grow uncontrollably, forming a tumor. In most cases, kidney cancer originates in the lining of the tiny tubes inside the kidneys (renal tubules). The cancer can spread (metastasize) to other parts of the body if not detected early. There are several types of kidney cancer, with the most common being renal cell carcinoma (RCC). Other less common types include urothelial carcinoma and Wilms tumor, which typically affects children. Causes and Risk Factors

Prostate Cancer: An Overview

Prostate cancer is a concern for men, particularly those over 50 or with a family history of the disease. Understanding prostate cancer is crucial for early detection and effective management. While the prospect of prostate cancer can be daunting, advancements in medical science have made it a highly manageable condition, especially when diagnosed early. In this article, I provide an overview of prostate cancer. Prostate cancer: Location of the prostate gland . Source . What is Prostate Cancer? Prostate cancer is a type of cancer that occurs in the prostate, a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm. This cancer is one of the most common types affecting men and tends to grow slowly, often confined to the prostate gland initially, where it may not cause significant harm. However, while some types of prostate cancer grow slowly and may need minimal or no treatment, others are aggressive and can spread quickly and become metasta

How is Kidney Cancer Diagnosed?

Understanding how kidney cancer is diagnosed is crucial for anyone seeking information about this disease, which starts in the kidneys—the organs responsible for filtering waste from the blood and creating urine. Early detection can significantly impact treatment outcomes, making awareness of the diagnostic process essential. This guide aims to break down the steps and methods used by healthcare professionals to diagnose kidney cancer, ensuring you are well-informed about this critical phase of cancer care. Recognizing the Symptoms Often, kidney cancer does not cause noticeable symptoms in its early stages. However, as the cancer grows, symptoms such as blood in the urine (hematuria), lower back pain on one side (not caused by injury), a mass or lump on the side or lower back, fatigue, unexplained weight loss, or fever may prompt a visit to the doctor. Recognizing these signs and seeking medical advice is the first step in the diagnostic process. Initial Consultation and Physical Exam

Pembrolizumab for Renal Cell Carcinoma

Pembrolizumab is a checkpoint inhibitor that belongs to a class of drugs called monoclonal antibodies. Pembrolizumab binds to a protein called programmed cell death-1 (PD-1) on the surface of immune cells called T cells, and prevents it from interacting with another protein called programmed cell death-ligand 1 (PD-L1) on the surface of cancer cells. This interaction normally inhibits the activation and function of T cells, allowing cancer cells to escape immune surveillance and attack. By blocking this interaction, pembrolizumab enhances the ability of T cells to recognize and kill cancer cells. Pembrolizumab, used in the treatment of renal cell carcinoma, is a checkpoint inhibitor and belongs to the class of drugs known as monoclonal antibodies. Source . Pembrolizumab and Axitinib for Renal Cell Carcinoma Pembrolizumab has been approved by the FDA for the treatment of renal cell carcinoma in different settings. In 2019, pembrolizumab was approved in combination with axitinib for the

Metastatic Prostate Cancer

Metastatic prostate cancer means that the cancer has spread beyond the prostate gland to other parts of the body. The likelihood of developing metastatic prostate cancer depends on various factors, including the stage and grade of the cancer at initial diagnosis, age, genetic predispositions, and overall health. Generally, prostate cancers identified early and at a lower grade have a lower risk of becoming metastatic. However, aggressive, or high-grade tumors are more likely to spread beyond the prostate. Bone metastasis of prostate cancer in F-18-Choline PET-CT Scan. Source . How does metastatic prostate cancer spread? Prostate cancer can metastasize to other internal organs in several ways. One method of metastasis is through the blood vessels, where the cancer cells enter the bloodstream and travel to distant organs. Another pathway is through the lymphatic system, wherein the cancer cells can infiltrate the lymph nodes near the prostate and subsequently spread to other lymph node

Benign Prostatic Hyperplasia or BPH

Benign prostatic hyperplasia, commonly known as BPH, is a common condition affecting the prostate gland of men as they age. Characterized by the enlargement of the prostate gland , BPH can significantly impact urinary function and quality of life. This enlargement is non-cancerous but can lead to uncomfortable urinary symptoms. Benign prostatic hyperplasia, commonly known as BPH, is the enlargement of the prostate gland affecting men as they age. Source . How common is benign prostatic hyperplasia? BPH is a very common condition, especially as men age. It is estimated that about half of men over the age of 50 have some degree of benign prostatic hyperplasia, with the number increasing to about 90% of men over 80. Despite its prevalence, not all men with an enlarged prostate experience significant symptom. What causes benign prostatic hyperplasia? The exact cause of benign prostatic hyperplasia is not fully understood, but it is believed to be linked to age-related hormonal changes. As

Urine Cytology to Diagnose Bladder Cancer

Urine cytology is a crucial diagnostic test used in the detection of bladder cancer. This test involves examining urine samples under a microscope to identify abnormal cells that could indicate the presence of cancer. This article provides an in-depth look at how urine cytology is used to diagnose bladder cancer, its effectiveness, and its role in the broader context of bladder cancer detection and monitoring. Understanding Urine Cytology Urine cytology is a non-invasive diagnostic procedure that helps detect bladder cancer , especially in its early stages. During this test, a urine sample collected from the patient is sent to a laboratory where a cytologist or a pathologist examines the sample under a microscope. The goal is to look for cancerous or pre-cancerous cells shed into the urine from the lining of the bladder. This test is particularly valuable because it can detect cells from tumors that might be missed by other diagnostic methods. How Urine Cytology Is Performed The proces

Prostate Specific Antigen (PSA)

Prostate specific antigen (PSA) is a protein produced by both normal and cancerous cells of the prostate gland. The PSA test measures the level of PSA in the blood and can help detect prostate cancer in men who have no symptoms. However, the PSA test is not perfect and has some limitations and controversies. In this blog post, we will discuss some of the important aspects of PSA testing, such as age-specific PSA levels, free and bound PSA, diagnostic value of PSA, and controversies surrounding PSA screening. Human prostate specific antigen with bound substrate from complex with antibody. Source . Age-specific PSA levels It is normal for all men to have some PSA in their blood, but the amount tends to increase with age. Therefore, some experts have suggested using age-specific PSA ranges to interpret the results of the PSA test. For example, one study proposed the following age-specific PSA ranges for men with no prostate cancer symptoms: 40 to 49 years: 0 to 2.5 ng/mL 50 to 59 years:

Pluvicto for Advanced Prostate Cancer

Pluvicto, also called Lutetium Lu 177 vipivotide tetraxetan, is a treatment option for men battling advanced prostate cancer. This article delves into the mechanics, benefits, and considerations of Pluvicto. Pluvicto, also called Lutetium Lu 177 vipivotide tetraxetan, is a treatment option for men battling advanced prostate cancer. Source . What is Pluvicto and How Does It Work? Pluvicto is a type of targeted radiation therapy, specifically formulated to attack prostate cancer cells expressing PSMA (prostate-specific membrane antigen). The drug consists of a PSMA-binding molecule linked to lutetium-177, a radioactive atom. When administered, Pluvicto targets PSMA-positive cancer cells, delivering potent radiation directly to the tumor sites while minimizing impact on healthy cells. This selective approach damages the DNA of cancer cells, leading to their destruction. The Dual Role of Pluvicto: Theranostic Applications One of the unique aspects of Pluvicto is its theranostic capability,

What are the Common Symptoms of Advanced Bladder Cancer?

Bladder cancer, a condition where cells in the bladder grow uncontrollably, can develop quietly over time. While early stages may not show clear signs, recognizing the common symptoms of advanced bladder cancer is crucial for timely intervention. This easy-to-understand guide outlines the symptoms you should be aware of, emphasizing the importance of consulting a healthcare provider if you notice these changes. Blood in the Urine One of the most noticeable signs of advanced bladder cancer is the presence of blood in the urine, which may appear pink, red, or cola-colored. This symptom, known medically as hematuria, is often the first warning sign that prompts individuals to seek medical advice. While it can be alarming, it is important to remember that blood in the urine does not automatically mean cancer, but it does require prompt medical evaluation. Changes in Urination Changes in urination patterns can signal advanced bladder cancer. This includes feeling the need to urinate more of

Urology Cancers: A blog about bladder, kidney, prostate, and Cancers

Search This Blog